Beta Bionics Inc (NAS:BBNX)

Q2 2025 Beta Bionics Inc Earnings Call Transcript

Jul 29, 2025 / 08:30 PM GMT

Release Date Price: $14.66 (+4.79%)

Transcript 10-Q8-K

Key Points

Positve

Beta Bionics Inc (BBNX) reported a 54% year-over-year increase in net sales, reaching $23.2 million for Q2 2025.
The company saw a 57% growth in new patient starts, with 4,934 new patients adopting the islet system.
Gross margin improved slightly to 53.8%, indicating effective cost management and manufacturing efficiency.
Beta Bionics Inc (BBNX) has expanded its sales force by 20 territories, enhancing its market reach.
The company raised its full-year 2025 guidance, projecting net sales between $88 to $93 million, up from the previous $82 to $87 million forecast.

Negative

The pharmacy channel's gross margin presents a short-term headwind due to the upfront revenue for the pump being forgone.
Operating expenses increased by 63% compared to the previous year, driven by sales team expansion and R&D projects.
The CMS proposal for a competitive bidding program and a shift to a pay-as-you-go rental model for insulin pumps could introduce financial uncertainties.
There is a potential risk of price compression in the Medicare fee-for-service channel, which could impact patient access and choice.
The company faces logistical complexities with the proposed CMS pay-as-you-go rental model for durable medical equipment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BBNX.OQ - Beta Bionics Inc
Q2 2025 Beta Bionics Inc Earnings Call
Jul 29, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the Beta Bionics 2nd quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question and answer session, and instructions will follow at that time. As a reminder, please be advised that today's conference is being recorded.

I would now like to turn the conference over to Blake Beaver, head of investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Good afternoon and thank you for tuning in to Beta Bionics 2nd quarter 2025

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.